Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaojian Han

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Frontiers in Medicine|November 7, 2022
Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infectionSong Mu, Shuyi Song, Yanan Hao, et al.
Frontiers in Immunology|December 24, 2021
A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant StrainsFengxia Gao, Jingjing Huang, Tingting Li, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2024
Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T cell receptors for cancer immunotherapy targeting hotspot driver mutationsMeiying Shen, Siyin Chen, Xiaojian Han, et al.
Genes & Diseases|July 5, 2021
Identification of cross-reactive CD8<sup>+</sup> T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variantsChao Hu, Meiying Shen, Xiaojian Han, et al.
Gut|December 17, 2025
PCK1 deficiency promotes MASH-HCC progression by 12-HETE-induced CD8<sup>+</sup> T cell dysfunctionKang Wu, Luo Li, Yi Liu, et al.
Frontiers in Immunology|April 8, 2021
A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2Xiaojian Han, Yingming Wang, Shenglong Li, et al.
JCI Insight|April 8, 2024
Prophylactic efficacy of an intranasal spray with 2 synergetic antibodies neutralizing OmicronXinghai Zhang, Feiyang Luo, Huajun Zhang, et al.
Nature Communications|November 3, 2021
Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variantsTingting Li, Xiaojian Han, Chenjian Gu, et al.
Cell Reports|January 22, 2023
Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortiumHeather M Callaway, Kathryn M Hastie, Sharon L Schendel, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Frontiers in Medicine|November 7, 2022
Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infectionSong Mu, Shuyi Song, Yanan Hao, et al.
Frontiers in Immunology|December 24, 2021
A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant StrainsFengxia Gao, Jingjing Huang, Tingting Li, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2024
Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T cell receptors for cancer immunotherapy targeting hotspot driver mutationsMeiying Shen, Siyin Chen, Xiaojian Han, et al.
Genes & Diseases|July 5, 2021
Identification of cross-reactive CD8<sup>+</sup> T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variantsChao Hu, Meiying Shen, Xiaojian Han, et al.
Gut|December 17, 2025
PCK1 deficiency promotes MASH-HCC progression by 12-HETE-induced CD8<sup>+</sup> T cell dysfunctionKang Wu, Luo Li, Yi Liu, et al.
Frontiers in Immunology|April 8, 2021
A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2Xiaojian Han, Yingming Wang, Shenglong Li, et al.
JCI Insight|April 8, 2024
Prophylactic efficacy of an intranasal spray with 2 synergetic antibodies neutralizing OmicronXinghai Zhang, Feiyang Luo, Huajun Zhang, et al.
Nature Communications|November 3, 2021
Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variantsTingting Li, Xiaojian Han, Chenjian Gu, et al.
Cell Reports|January 22, 2023
Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortiumHeather M Callaway, Kathryn M Hastie, Sharon L Schendel, et al.
Pageof 3